Ziv Lifshitz

678 citations
10 papers · 501 indexed · h-index 8
Topics
Vibrio bacteria research studies (5 papers)Antibiotic Resistance in Bacteria (5 papers)Legionella and Acanthamoeba research (4 papers)
Partner nations
IsraelUnited StatesJapan

In The Last Decade

Ziv Lifshitz

10 papers receiving 497 citations

Peers

Ziv Lifshitz
Comparison fields: 5 of 46
  • Endocrinology 365
  • Molecular Biology 220
  • Immunology 127
  • Parasitology 80
  • Molecular Medicine 72
Replace Deanna Deveson Lucas with:
Deanna Deveson Lucas Australia
Elizabeth Garduño Canada
Philipp Auraß Germany
Sonia Mondino France
Karim Suwwan de Felipe United States
Bethany L. Tiner United States
Chen Ai Khoo Australia
Quanshun Zhang United States
Reija Venho Finland
Anna M. Kolodziejek United States
Ziv Lifshitz relative to Deanna Deveson Lucas Australia Deanna Deveson Lucas's profile →
Citations per field
00.5×4.9×
Deanna Deveson Lucas · 1×
Citations per year

Countries citing papers authored by Ziv Lifshitz

Since Specialization
Citations

This map shows the geographic impact of Ziv Lifshitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziv Lifshitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziv Lifshitz more than expected).

Fields of papers citing papers by Ziv Lifshitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziv Lifshitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziv Lifshitz. The network helps show where Ziv Lifshitz may publish in the future.

Co-authorship network of co-authors of Ziv Lifshitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ziv Lifshitz. A scholar is included among the top collaborators of Ziv Lifshitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziv Lifshitz. Ziv Lifshitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 9
2 5
3 8
4 7
5 13
6 203
7 22
8 52
9 34
10 148

About Ziv Lifshitz

Ziv Lifshitz is a scholar working on Endocrinology, Molecular Medicine and Parasitology, having authored 10 papers that have together received 501 indexed citations. Recurring topics across this work include Vibrio bacteria research studies (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Legionella and Acanthamoeba research (4 papers). The work is most often cited by research in Endocrinology (365 citations), Molecular Medicine (72 citations) and Parasitology (80 citations). Ziv Lifshitz has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Gil Segal, Howard A. Shuman, David Burstein, Tal Zusman, Tal Pupko, Francisco Amaro, Jack A. Gilbert, Ofir Cohen, Amos Adler and Yehuda Carmeli. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026